×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
Yahoo Finance
Highlights: Immuron proceeding to Phase 3 registration strategy with the FDATravelan® topline clinical trial results demonstrate protective...
2 months ago
Immuron Director Resignation
GlobeNewswire
MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
3 weeks ago
Immuron Limited Announces Board Reshuffle - TipRanks.com
Tipranks
Immuron Limited (AU:IMC) has released an update. Stephen Anastasiou has stepped down from his role as Non-Executive Director at Immuron Limited to...
3 weeks ago
Immuron stock surges after mid-stage data for Travelan
Seeking Alpha
Immuron (IMRN) stock surges in premarket after positive Phase 2 trial results for its antidiarrheal medicine, Travelan. Read more here.
2 months ago
Immuron Shares Soar Premarket on Positive Travelan Study
MarketWatch
By Colin Kellaher U.S.-listed shares of Immuron more than doubled in premarket trading Thursday after the biopharmaceutical company reported...
2 months ago
Immuron Travelan® sales continued strong growth
Yahoo Finance
Sales Highlights: Global FYTD Mar 2024 AUD$3.6 million up 154% on (prior comparative period) pcpMar 2024 Quarter AUD$1.3 million up 51% on...
1 month ago
Immuron Limited to Present at the Emerging Growth Conference
GlobeNewswire
MELBOURNE, Australia, May 07, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated...
2 weeks ago
Immuron doubles on promising Travelan® Phase 2 results, advancing to Phase 3 trials in US
Proactive Investors Australia
Use of technology ... Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has doubled on receiving positive interim topline results from its Phase 2 clinical trial...
2 months ago
We're Not Very Worried About Immuron's (ASX:IMC) Cash Burn Rate
Simply Wall Street
Stock Analysis · Market is not liking Michael Hill International's (ASX:MHJ) earnings decline as stock retreats 24% this week · Lacklustre...
2 months ago
Immuron CEO to Discuss Travelan® and Future Plans - TipRanks.com
Tipranks
Immuron Limited (AU:IMC) has released an update. Immuron Limited, an Australian biopharmaceutical company, announces that CEO Steven...
1 month ago